전남대학교 중앙도서관

  • 중앙도서관
  • 여수캠퍼스도서관
  • 법학도서관
  • 치의학도서관
  • 의학도서관

주메뉴

전체메뉴


전자자료 상세검색

전자자료 상세검색

통합검색
상세검색
검색어 [키워드: "Minassian AM"]
55건 
※ 페이지 이동 시, 중복 레코드가 제거되므로 초기 검색결과 수와 차이가 있을 수 있습니다.
4/6 페이지 RSS 엑셀파일 출력
검색결과수정
  • 검색범위확장
    • Full Text내 키워드 확장
    • 관련 주제어 확장

    재검색

  • 검색결과제한
    • 원문(Full Text)
    • Peer-Reviewed 학술지
    • 발행년 -

    재검색

  • 자료유형
    • Academic Journals (55)

    재검색

  • 주제
    • covid-19 (13)
    • covid-19 vaccines (11)
    • malaria, falciparum (11)

    더보기

    재검색

  • 간행물
    • lancet london england (8)
    • frontiers in immunology (6)
    • journal of infectious diseases (5)

    더보기

    재검색

  • 출판사
    • elsevier (9)
    • frontiers research foundation] (6)
    • american society for clinical investigation (4)

    더보기

    재검색

  • 언어
    • english (55)

    재검색

  • 수록데이터베이스
    • MEDLINE (52)
    • Academic Search Complete (1)
    • CINAHL Plus with Full Text (1)

    더보기

    재검색

  • PQDTSearch
  • CAJSearch
  • RISSSearch
  • PsycINFOSearch

 

31

학술저널

issue
Lancet (London, England) [Lancet] 2021 Apr 10; Vol. 397 (10282), pp. 1351-1362. Date of Electronic Publication: 2021 Mar 30.
Author
Emary KRW; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Golubchik T; Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Aley PK; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Ariani CV; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
Angus B; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Bibi S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Blane B; COVID-19 Genomics UK, Department of Medicine, University of Cambridge, Cambridge, UK.
Bonsall D; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Cicconi P; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Charlton S; National Infection Service, Public Health England, Salisbury, UK.
Clutterbuck EA; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Collins AM; Department of Clinical Sciences, Liverpool School of Tropical Medicine and Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
Cox T; UK Biocentre, Milton Keynes, UK.
Darton TC; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK; Department of Infection and Tropical Medicine, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Dold C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Douglas AD; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Duncan CJA; Department of Infection and Tropical Medicine, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK; Translational and Clinical Research Institute, Immunity and Inflammation Theme, Newcastle University, Newcastle upon Tyne, UK.
Ewer KJ; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Flaxman AL; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Faust SN; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK.
Ferreira DM; Department of Clinical Sciences, Liverpool School of Tropical Medicine and Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
Feng S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Finn A; University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
Folegatti PM; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Fuskova M; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Galiza E; St George's Vaccine Institute, St George's, University of London, London, UK.
Goodman AL; Department of Infection, Guy's and St Thomas' NHS Foundation Trust, St Thomas' Hospital, London, UK; MRC Clinical Trials Unit, University College London, London, UK.
Green CM; Clinical BioManufacturing Facility, University of Oxford, Oxford, UK.
Green CA; NIHR/Wellcome Trust Clinical Research Facility, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Greenland M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Hallis B; National Infection Service, Public Health England, Salisbury, UK.
Heath PT; St George's Vaccine Institute, St George's, University of London, London, UK.
Hay J; University of Glasgow, Glasgow, UK; Lighthouse Laboratory in Glasgow, Queen Elizabeth University Hospital, Glasgow, UK.
Hill HC; Department of Clinical Sciences, Liverpool School of Tropical Medicine and Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
Jenkin D; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Kerridge S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Lazarus R; Severn Pathology, North Bristol NHS Trust, Bristol, UK.
Libri V; NIHR UCLH Clinical Research Facility, London, UK; NIHR UCLH Biomedical Research Centre, London, UK.
Lillie PJ; Hull University Teaching Hospitals NHS Trust, Hull, UK.
Ludden C; COVID-19 Genomics UK, Department of Medicine, University of Cambridge, Cambridge, UK.
Marchevsky NG; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Minassian AM; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
McGregor AC; London Northwest University Healthcare, Harrow, UK.
Mujadidi YF; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Phillips DJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Plested E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Pollock KM; NIHR Imperial Clinical Research Facility, London, UK; NIHR Imperial Biomedical Research Centre, London, UK.
Robinson H; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Smith A; College of Medical, Veterinary & Life Sciences, Glasgow Dental Hospital and School, University of Glasgow, Glasgow, UK.
Song R; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Snape MD; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Sutherland RK; Clinical Infection Research Group, Regional Infectious Diseases Unit, Western General Hospital, Edinburgh, UK.
Thomson EC; MRC University of Glasgow Centre for Virus Research, Glasgow, UK; Severn Pathology, North Bristol NHS Trust, Bristol, UK; Department of Infectious Diseases, Queen Elizabeth University Hospital, Glasgow, UK.
Toshner M; Heart Lung Research Institute, Department of Medicine, University of Cambridge, Cambridge, UK; NIHR Cambridge Clinical Research Facility, Cambridge, UK; Cambridge University Hospital and Royal Papworth NHS Foundation Trusts, Cambridge, UK.
Turner DPJ; University of Nottingham, Nottingham, UK; Nottingham University Hospitals NHS Trust, Nottingham, UK.
Vekemans J; AstraZeneca BioPharmaceuticals, Gaithersburg, MD, USA.
Villafana TL; AstraZeneca BioPharmaceuticals, Gaithersburg, MD, USA.
Williams CJ; Public Health Wales, Cardiff, UK; Aneurin Bevan University Health Board, Newport, UK.
Hill AVS; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Lambe T; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Gilbert SC; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Voysey M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Ramasamy MN; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. Electronic address: maheshi.ramasamy@paediatrics.ox.ac.uk.
Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
DB Label
Database : MEDLINE
원문보기
32

학술저널

issue
Lancet (London, England) [Lancet] 2021 Mar 06; Vol. 397 (10277), pp. 881-891. Date of Electronic Publication: 2021 Feb 19.
Author
Voysey M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Costa Clemens SA; Institute of Global Health, University of Siena, Siena, Italy; Department of Paediatrics, University of Oxford, Oxford, UK.
Madhi SA; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa.
Weckx LY; Department of Pediatrics, Universidade Federal de São Paulo, São Paulo, Brazil.
Folegatti PM; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Aley PK; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Angus B; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Baillie VL; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa.
Barnabas SL; Family Centre for Research with Ubuntu, Department of Paediatrics, University of Stellenbosch, Cape Town, South Africa.
Bhorat QE; Soweto Clinical Trials Centre, Soweto, South Africa.
Bibi S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Briner C; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Cicconi P; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Clutterbuck EA; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Collins AM; Department of Clinical Sciences, Liverpool School of Tropical Medicine and Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
Cutland CL; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa.
Darton TC; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK; Department of Infection and Tropical Medicine, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Dheda K; Division of Pulmonology, Groote Schuur Hospital and the University of Cape Town, Cape Town, South Africa; Faculty of Infectious and Tropical Diseases, Department of Immunology and Infection, London School of Hygiene & Tropical Medicine, London, UK.
Dold C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Duncan CJA; Department of Infection and Tropical Medicine, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK; Translational and Clinical Research Institute, Immunity and Inflammation Theme, Newcastle University, Newcastle upon Tyne, UK.
Emary KRW; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Ewer KJ; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Flaxman A; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Fairlie L; Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Faust SN; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, University of Southampton, Southampton, UK; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK.
Feng S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Ferreira DM; Department of Clinical Sciences, Liverpool School of Tropical Medicine and Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
Finn A; School of Population Health Sciences, University of Bristol and University Hospitals Bristol and Weston NHS Foundation Trust, UK.
Galiza E; St George's Vaccine Institute, St George's, University of London, London, UK.
Goodman AL; Department of Infection, Guy's and St Thomas' NHS Foundation Trust, St Thomas' Hospital, London, UK; MRC Clinical Trials Unit, University College London, London, UK.
Green CM; Clinical BioManufacturing Facility, University of Oxford, Oxford, UK.
Green CA; NIHR/Wellcome Trust Clinical Research Facility, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Greenland M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Hill C; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa.
Hill HC; Department of Clinical Sciences, Liverpool School of Tropical Medicine and Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
Hirsch I; AstraZeneca BioPharmaceuticals, Cambridge, UK.
Izu A; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa.
Jenkin D; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Joe CCD; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Kerridge S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Koen A; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa.
Kwatra G; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa.
Lazarus R; Severn Pathology, North Bristol NHS Trust, Bristol, UK.
Libri V; NIHR UCLH Clinical Research Facility and NIHR UCLH Biomedical Research Centre, London, UK.
Lillie PJ; Department of Infection, Hull University Teaching Hospitals NHS Trust, Hull, UK.
Marchevsky NG; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Marshall RP; AstraZeneca BioPharmaceuticals, Cambridge, UK.
Mendes AVA; Escola Bahiana de Medicina e Saúde Pública, Salvador, Braziland Hospital São Rafael, Salvador, Brazil; Instituto D'Or, Salvador, Brazil.
Milan EP; Universidade Federal do Rio Grande do Norte, Natal, Brazil.
Minassian AM; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
McGregor A; London Northwest University Healthcare, Harrow, UK.
Mujadidi YF; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Nana A; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Padayachee SD; Setshaba Research Centre, Pretoria, South Africa.
Phillips DJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Pittella A; Hospital Quinta D'Or, Rede D'Or, Rio De Janeiro, Brazil.
Plested E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Pollock KM; NIHR Imperial Clinical Research Facility and NIHR Imperial Biomedical Research Centre, London, UK.
Ramasamy MN; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Ritchie AJ; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Robinson H; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Schwarzbold AV; Clinical Research Unit, Department of Clinical Medicine, Universidade Federal de Santa Maria, Santa Maria, Brazil.
Smith A; College of Medical, Veterinary & Life Sciences, Glasgow Dental Hospital & School, University of Glasgow, Glasgow, UK.
Song R; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Snape MD; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Sprinz E; Infectious Diseases Service, Hospital de Clinicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Sutherland RK; Clinical Infection Research Group, Regional Infectious Diseases Unit, Western General Hospital, Edinburgh, UK.
Thomson EC; MRC-University of Glasgow Centre for Virus Research & Department of Infectious Diseases, Queen Elizabeth University Hospital, Glasgow, UK.
Török ME; Department of Medicine, University of Cambridge, UK; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Toshner M; Heart Lung Research Institute, Dept of Medicine, University of Cambridge and NIHR Cambridge Clinical Research Facility, Cambridge University Hospital and Royal Papworth NHS Foundation Trusts, Cambridge, UK.
Turner DPJ; University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK.
Vekemans J; AstraZeneca BioPharmaceuticals, Cambridge, UK.
Villafana TL; AstraZeneca BioPharmaceuticals, Cambridge, UK.
White T; AstraZeneca BioPharmaceuticals, Cambridge, UK.
Williams CJ; Public Health Wales, Cardiff, Wales; Aneurin Bevan University Health Board, Newport, Wales.
Douglas AD; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Hill AVS; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Lambe T; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Gilbert SC; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. Electronic address: andrew.pollard@paediatrics.ox.ac.uk.
DB Label
Database : MEDLINE
원문보기
33

학술저널

issue
ELife [Elife] 2021 Mar 02; Vol. 10. Date of Electronic Publication: 2021 Mar 02.
Author
Milne K; Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh, United Kingdom.
Ivens A; Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh, United Kingdom.; Centre for Immunity, Infection and Evolution, University of Edinburgh, Edinburgh, United Kingdom.
Reid AJ; Wellcome Sanger Institute, Cambridge, United Kingdom.
Lotkowska ME; Wellcome Sanger Institute, Cambridge, United Kingdom.
O'Toole A; Centre for Immunity, Infection and Evolution, University of Edinburgh, Edinburgh, United Kingdom.; Institute of Evolutionary Biology, University of Edinburgh, Edinburgh, United Kingdom.
Sankaranarayanan G; Wellcome Sanger Institute, Cambridge, United Kingdom.
Munoz Sandoval D; Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh, United Kingdom.; Instituto de Microbiologia, Universidad San Francisco de Quito, Quito, Ecuador.
Nahrendorf W; Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh, United Kingdom.
Regnault C; Wellcome Centre for Integrative Parasitology, University of Glasgow, Glasgow, United Kingdom.; Glasgow Polyomics, University of Glasgow, Glasgow, United Kingdom.
Edwards NJ; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
Silk SE; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
Payne RO; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
Minassian AM; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
Venkatraman N; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
Sanders MJ; Wellcome Sanger Institute, Cambridge, United Kingdom.
Hill AV; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
Barrett M; Wellcome Centre for Integrative Parasitology, University of Glasgow, Glasgow, United Kingdom.; Glasgow Polyomics, University of Glasgow, Glasgow, United Kingdom.
Berriman M; Wellcome Sanger Institute, Cambridge, United Kingdom.
Draper SJ; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
Rowe JA; Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh, United Kingdom.; Centre for Immunity, Infection and Evolution, University of Edinburgh, Edinburgh, United Kingdom.
Spence PJ; Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh, United Kingdom.; Centre for Immunity, Infection and Evolution, University of Edinburgh, Edinburgh, United Kingdom.
DB Label
Database : MEDLINE
원문보기
34

학술저널

issue
Cell reports. Medicine [Cell Rep Med] 2021 Feb 22; Vol. 2 (3), pp. 100207. Date of Electronic Publication: 2021 Feb 22 (Print Publication: 2021).
Author
Nielsen CM; Jenner Institute, University of Oxford, Oxford, UK.
Ogbe A; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
Pedroza-Pacheco I; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
Doeleman SE; Jenner Institute, University of Oxford, Oxford, UK.
Chen Y; Human Vaccine Institute, Duke University School of Medicine, Duke University, Durham, NC, USA.
Silk SE; Jenner Institute, University of Oxford, Oxford, UK.
Barrett JR; Jenner Institute, University of Oxford, Oxford, UK.
Elias SC; Jenner Institute, University of Oxford, Oxford, UK.
Miura K; Laboratory of Malaria and Vector Research, NIAID/NIH, Rockville, MD, USA.
Diouf A; Laboratory of Malaria and Vector Research, NIAID/NIH, Rockville, MD, USA.
Bardelli M; Jenner Institute, University of Oxford, Oxford, UK.
Dabbs RA; Jenner Institute, University of Oxford, Oxford, UK.
Barfod L; Jenner Institute, University of Oxford, Oxford, UK.
Long CA; Laboratory of Malaria and Vector Research, NIAID/NIH, Rockville, MD, USA.
Haynes BF; Human Vaccine Institute, Duke University School of Medicine, Duke University, Durham, NC, USA.
Payne RO; Jenner Institute, University of Oxford, Oxford, UK.
Minassian AM; Jenner Institute, University of Oxford, Oxford, UK.
Bradley T; Human Vaccine Institute, Duke University School of Medicine, Duke University, Durham, NC, USA.
Draper SJ; Jenner Institute, University of Oxford, Oxford, UK.
Borrow P; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
DB Label
Database : MEDLINE
원문보기
35

학술저널

issue
Nature medicine [Nat Med] 2021 Feb; Vol. 27 (2), pp. 270-278. Date of Electronic Publication: 2020 Dec 17.
Author
Ewer KJ; The Jenner Institute, University of Oxford, Oxford, UK. katie.ewer@ndm.ox.ac.uk.
Barrett JR; The Jenner Institute, University of Oxford, Oxford, UK.
Belij-Rammerstorfer S; The Jenner Institute, University of Oxford, Oxford, UK.
Sharpe H; The Jenner Institute, University of Oxford, Oxford, UK.
Makinson R; The Jenner Institute, University of Oxford, Oxford, UK.
Morter R; The Jenner Institute, University of Oxford, Oxford, UK.
Flaxman A; The Jenner Institute, University of Oxford, Oxford, UK.
Wright D; The Jenner Institute, University of Oxford, Oxford, UK.
Bellamy D; The Jenner Institute, University of Oxford, Oxford, UK.
Bittaye M; The Jenner Institute, University of Oxford, Oxford, UK.
Dold C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Provine NM; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Aboagye J; The Jenner Institute, University of Oxford, Oxford, UK.
Fowler J; The Jenner Institute, University of Oxford, Oxford, UK.
Silk SE; The Jenner Institute, University of Oxford, Oxford, UK.
Alderson J; The Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Aley PK; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Angus B; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Berrie E; Clinical Biomanufacturing Facility, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Bibi S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Cicconi P; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Clutterbuck EA; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Chelysheva I; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Folegatti PM; The Jenner Institute, University of Oxford, Oxford, UK.
Fuskova M; The Jenner Institute, University of Oxford, Oxford, UK.
Green CM; Clinical Biomanufacturing Facility, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Jenkin D; The Jenner Institute, University of Oxford, Oxford, UK.
Kerridge S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Lawrie A; The Jenner Institute, University of Oxford, Oxford, UK.
Minassian AM; The Jenner Institute, University of Oxford, Oxford, UK.
Moore M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Mujadidi Y; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Plested E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Poulton I; The Jenner Institute, University of Oxford, Oxford, UK.
Ramasamy MN; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Robinson H; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Song R; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Snape MD; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Tarrant R; Clinical Biomanufacturing Facility, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Voysey M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Watson MEE; The Jenner Institute, University of Oxford, Oxford, UK.
Douglas AD; The Jenner Institute, University of Oxford, Oxford, UK.
Hill AVS; The Jenner Institute, University of Oxford, Oxford, UK.
Gilbert SC; The Jenner Institute, University of Oxford, Oxford, UK.
Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Lambe T; The Jenner Institute, University of Oxford, Oxford, UK. Teresa.lambe@ndm.ox.ac.uk.
DB Label
Database : MEDLINE
원문보기
36

학술저널

issue
Lancet (London, England) [Lancet] 2021 Jan 09; Vol. 397 (10269), pp. 99-111. Date of Electronic Publication: 2020 Dec 08.
Author
Voysey M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Clemens SAC; Institute of Global Health, University of Siena, Siena, Brazil; Department of Paediatrics, University of Oxford, Oxford, UK.
Madhi SA; MRC Vaccines and Infectious Diseases Analytics Research Unit, Johannesburg, South Africa.
Weckx LY; Department of Pediatrics, Universidade Federal de São Paulo, São Paulo, Brazil.
Folegatti PM; Jenner Institute, Nuffield Department of Medicine, University of Oxford, UK.
Aley PK; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Angus B; Jenner Institute, Nuffield Department of Medicine, University of Oxford, UK.
Baillie VL; Respiratory and Meningeal Pathogens Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
Barnabas SL; Family Centre for Research with Ubuntu, Department of Paediatrics, University of Stellenbosch, Cape Town, South Africa.
Bhorat QE; Soweto Clinical Trials Centre, Soweto, South Africa.
Bibi S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Briner C; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Cicconi P; Jenner Institute, Nuffield Department of Medicine, University of Oxford, UK.
Collins AM; Department of Clinical Sciences, Liverpool School of Tropical Medicine and Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
Colin-Jones R; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Cutland CL; Respiratory and Meningeal Pathogens Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
Darton TC; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK; Department of Infection and Tropical Medicine, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Dheda K; Division of Pulmonology, Groote Schuur Hospital and the University of Cape Town, South Africa; Faculty of Infectious and Tropical Diseases, Department of Immunology and Infection, London School of Hygiene & Tropical Medicine, London, UK.
Duncan CJA; Department of Infection and Tropical Medicine, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK; Translational and Clinical Research Institute, Immunity and Inflammation Theme, Newcastle University, Newcastle upon Tyne, UK.
Emary KRW; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Ewer KJ; Jenner Institute, Nuffield Department of Medicine, University of Oxford, UK.
Fairlie L; Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Faust SN; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK.
Feng S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Ferreira DM; Department of Clinical Sciences, Liverpool School of Tropical Medicine and Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
Finn A; School of Population Health Sciences, University of Bristol and University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
Goodman AL; Department of Infection, Guy's and St Thomas' NHS Foundation Trust, St Thomas' Hospital, London, UK; MRC Clinical Trials Unit, University College London, London, UK.
Green CM; Clinical BioManufacturing Facility, University of Oxford, Oxford, UK.
Green CA; NIHR/Wellcome Trust Clinical Research Facility, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Heath PT; St George's Vaccine Institute, St George's, University of London, London, UK.
Hill C; Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Hill H; Department of Clinical Sciences, Liverpool School of Tropical Medicine and Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
Hirsch I; AstraZeneca BioPharmaceuticals, Cambridge, UK.
Hodgson SHC; Jenner Institute, Nuffield Department of Medicine, University of Oxford, UK.
Izu A; VIDA-Vaccines and Infectious Diseases Analytical Research Unit, Johannesburg, South Africa.
Jackson S; Jenner Institute, Nuffield Department of Medicine, University of Oxford, UK.
Jenkin D; Jenner Institute, Nuffield Department of Medicine, University of Oxford, UK.
Joe CCD; Jenner Institute, Nuffield Department of Medicine, University of Oxford, UK.
Kerridge S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Koen A; VIDA-Vaccines and Infectious Diseases Analytical Research Unit, Johannesburg, South Africa.
Kwatra G; Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Lazarus R; Severn Pathology, North Bristol NHS Trust, Bristol, UK.
Lawrie AM; Jenner Institute, Nuffield Department of Medicine, University of Oxford, UK.
Lelliott A; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Libri V; NIHR UCLH Clinical Research Facility and NIHR UCLH Biomedical Research Centre, London, UK.
Lillie PJ; Department of Infection, Hull University Teaching Hospitals NHS Trust, UK.
Mallory R; AstraZeneca BioPharmaceuticals, Cambridge, UK.
Mendes AVA; Escola Bahiana de Medicina e Saúde Pública, Salvador, Braziland Hospital São Rafael, Salvador, Brazil; Instituto D'Or, Salvador, Brazil.
Milan EP; Department of Infectious Diseases, Universidade Federal do Rio Grande do Norte, Natal, Brazil.
Minassian AM; Jenner Institute, Nuffield Department of Medicine, University of Oxford, UK.
McGregor A; London Northwest University Healthcare, Harrow, UK.
Morrison H; Jenner Institute, Nuffield Department of Medicine, University of Oxford, UK.
Mujadidi YF; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Nana A; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
O'Reilly PJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Padayachee SD; Setshaba Research Centre, Pretoria, South Africa.
Pittella A; Department of Internal Medicine, Hospital Quinta D'Or, Rio de Janeiro, Brazil; Instituto D'Or de Pesquisa e Ensino (IDOR), Rio de Janeiro, Brazil; Department of Internal Medicine, Universidade UNIGRANRIO, Rio de Janeiro, Brazil.
Plested E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Pollock KM; NIHR Imperial Clinical Research Facility and NIHR Imperial Biomedical Research Centre, London, UK.
Ramasamy MN; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Rhead S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Schwarzbold AV; Clinical Research Unit, Department of Clinical Medicine, Universidade Federal de Santa Maria, Santa Maria, Brazil.
Singh N; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Smith A; College of Medical, Veterinary & Life Sciences, Glasgow Dental Hospital & School, University of Glasgow, Glasgow, UK.
Song R; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA.
Snape MD; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Sprinz E; Infectious Diseases Service, Hospital de Clinicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Sutherland RK; Clinical Infection Research Group, Regional Infectious Diseases Unit, Western General Hospital, Edinburgh, UK.
Tarrant R; Clinical BioManufacturing Facility, University of Oxford, Oxford, UK.
Thomson EC; MRC-University of Glasgow Centre for Virus Research & Department of Infectious Diseases, Queen Elizabeth University Hospital, Glasgow, UK.
Török ME; Department of Medicine, University of Cambridge, UK; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Toshner M; Heart Lung Research Institute, Department of Medicine, University of Cambridge and Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK.
Turner DPJ; University of Nottingham and Nottingham University Hospitals NHS Trust, UK.
Vekemans J; AstraZeneca BioPharmaceuticals, Cambridge, UK.
Villafana TL; AstraZeneca BioPharmaceuticals, Cambridge, UK.
Watson MEE; Jenner Institute, Nuffield Department of Medicine, University of Oxford, UK.
Williams CJ; Public Health Wales, Cardiff, Wales; Aneurin Bevan University Health Board, Newport, UK.
Douglas AD; Jenner Institute, Nuffield Department of Medicine, University of Oxford, UK.
Hill AVS; Jenner Institute, Nuffield Department of Medicine, University of Oxford, UK.
Lambe T; Jenner Institute, Nuffield Department of Medicine, University of Oxford, UK.
Gilbert SC; Jenner Institute, Nuffield Department of Medicine, University of Oxford, UK.
Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. Electronic address: andrew.pollard@paediatrics.ox.ac.uk.
DB Label
Database : MEDLINE
원문보기
37

학술저널

issue
Lancet (London, England) [Lancet] 2020 Aug 15; Vol. 396 (10249), pp. 467-478. Date of Electronic Publication: 2020 Jul 20.
Author
Folegatti PM; The Jenner Institute, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Ewer KJ; The Jenner Institute, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Aley PK; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Angus B; Nuffield Department of Medicine, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Becker S; Institute of Virology, Philipps University of Marburg, Marburg, Germany.
Belij-Rammerstorfer S; The Jenner Institute, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Bellamy D; The Jenner Institute, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Bibi S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Bittaye M; The Jenner Institute, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Clutterbuck EA; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Dold C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Faust SN; NIHR Southampton Clinical Research Facility, University Hospital Southampton NHS Foundation Trust and University of Southampton, Southampton, UK.
Finn A; School of Population Health Sciences, University of Bristol, Bristol, UK.
Flaxman AL; The Jenner Institute, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Hallis B; National Infection Service, Public Health England, Salisbury, UK.
Heath P; Vaccine Institute, St George's University, London, UK.
Jenkin D; The Jenner Institute, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Lazarus R; Department of Microbiology, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
Makinson R; The Jenner Institute, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Minassian AM; The Jenner Institute, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Pollock KM; NIHR Imperial Clinical Research Facility, Imperial College London, London, UK.
Ramasamy M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Robinson H; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Snape M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Tarrant R; Clinical Biomanufacturing Facility, University of Oxford, Oxford, UK.
Voysey M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Green C; Clinical Biomanufacturing Facility, University of Oxford, Oxford, UK.
Douglas AD; The Jenner Institute, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Hill AVS; The Jenner Institute, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Lambe T; The Jenner Institute, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Gilbert SC; The Jenner Institute, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK. Electronic address: andrew.pollard@paediatrics.ox.ac.uk.
DB Label
Database : MEDLINE
원문보기
38

학술저널

issue
Frontiers in immunology [Front Immunol] 2020 Apr 07; Vol. 11, pp. 442. Date of Electronic Publication: 2020 Apr 07 (Print Publication: 2020).
Author
De Groot AS; EpiVax, Inc., Providence, RI, United States.; Institute for Immunology and Informatics, Providence, RI, United States.
Moise L; EpiVax, Inc., Providence, RI, United States.; Institute for Immunology and Informatics, Providence, RI, United States.
Terry F; EpiVax, Inc., Providence, RI, United States.
Gutierrez AH; EpiVax, Inc., Providence, RI, United States.; Institute for Immunology and Informatics, Providence, RI, United States.
Hindocha P; EpiVax, Inc., Providence, RI, United States.
Richard G; EpiVax Oncology, Inc., New York, NY, United States.
Hoft DF; Departments of Molecular Microbiology & Immunology and Internal Medicine, Division of Infectious Diseases, Allergy & Immunology, Saint Louis University, St. Louis, MO, United States.
Ross TM; Center for Vaccines and Immunology, University of Georgia, Athens, GA, United States.
Noe AR; Leidos Life Sciences, Frederick, MD, United States.
Takahashi Y; National Institute of Infectious Diseases, Tokyo, Japan.
Kotraiah V; Leidos Life Sciences, Frederick, MD, United States.
Silk SE; Jenner Institute, University of Oxford, Oxford, United Kingdom.
Nielsen CM; Jenner Institute, University of Oxford, Oxford, United Kingdom.
Minassian AM; Jenner Institute, University of Oxford, Oxford, United Kingdom.
Ashfield R; Jenner Institute, University of Oxford, Oxford, United Kingdom.
Ardito M; EpiVax, Inc., Providence, RI, United States.
Draper SJ; Jenner Institute, University of Oxford, Oxford, United Kingdom.
Martin WD; EpiVax, Inc., Providence, RI, United States.
DB Label
Database : MEDLINE
원문보기
39

학술저널

issue
Frontiers in immunology [Front Immunol] 2020 Jan 10; Vol. 10, pp. 2983. Date of Electronic Publication: 2020 Jan 10 (Print Publication: 2019).
Author
Tanner R; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Satti I; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Harris SA; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
O'Shea MK; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.; Institute of Microbiology and Infection, College of Medical and Dental Sciences, The University of Birmingham, Birmingham, United Kingdom.
Cizmeci D; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
O'Connor D; Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
Chomka A; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Matsumiya M; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Wittenberg R; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Minassian AM; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Meyer J; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Fletcher HA; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.; London School of Hygiene and Tropical Medicine, London, United Kingdom.
McShane H; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
DB Label
Database : MEDLINE
원문보기
40

학술저널

issue
Nature microbiology [Nat Microbiol] 2019 Sep; Vol. 4 (9), pp. 1497-1507. Date of Electronic Publication: 2019 May 27.
Author
Rawlinson TA; Jenner Institute, University of Oxford, Oxford, UK.
Barber NM; Department of Biochemistry, University of Oxford, Oxford, UK.
Mohring F; Department of Immunology and Infection, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Cho JS; Jenner Institute, University of Oxford, Oxford, UK.
Kosaisavee V; Faculty of Public Health, Mahidol University, Bangkok, Thailand.
Gérard SF; Department of Biochemistry, University of Oxford, Oxford, UK.
Alanine DGW; Jenner Institute, University of Oxford, Oxford, UK.
Labbé GM; Jenner Institute, University of Oxford, Oxford, UK.
Elias SC; Jenner Institute, University of Oxford, Oxford, UK.
Silk SE; Jenner Institute, University of Oxford, Oxford, UK.
Quinkert D; Jenner Institute, University of Oxford, Oxford, UK.
Jin J; Jenner Institute, University of Oxford, Oxford, UK.
Marshall JM; Jenner Institute, University of Oxford, Oxford, UK.
Payne RO; Jenner Institute, University of Oxford, Oxford, UK.
Minassian AM; Jenner Institute, University of Oxford, Oxford, UK.
Russell B; Department of Microbiology and Immunology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand.
Rénia L; Singapore Immunology Network, A*STAR, Singapore, Singapore.
Nosten FH; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Shoklo Malaria Research Unit, Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Moon RW; Department of Immunology and Infection, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Higgins MK; Department of Biochemistry, University of Oxford, Oxford, UK. matthew.higgins@bioch.ox.ac.uk.
Draper SJ; Jenner Institute, University of Oxford, Oxford, UK. simon.draper@ndm.ox.ac.uk.
DB Label
Database : MEDLINE
원문보기
1 2 3 4 5  

QUICK LINK

  • 희망도서신청
  • 대출/연장조회
  • 서가부재도서
  • 이용교육

마이메뉴추가


QRCode
  • 개인정보호정책
  • 이메일무단수집거부
  • 도서관이용문의

  • 도서관자치위원회  원격제어  Instagram  facebook  w  kakao 플친
500-757 광주광역시 북구 용봉로 77   TEL  062)530-3571~2(대출반납실)   FAX  062)530-3529
  • 179382
  • 128236810